Øystein Bruserud

10.6k total citations · 1 hit paper
350 papers, 8.2k citations indexed

About

Øystein Bruserud is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Øystein Bruserud has authored 350 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 224 papers in Hematology, 142 papers in Molecular Biology and 98 papers in Immunology. Recurrent topics in Øystein Bruserud's work include Acute Myeloid Leukemia Research (151 papers), Hematopoietic Stem Cell Transplantation (68 papers) and Immune Cell Function and Interaction (40 papers). Øystein Bruserud is often cited by papers focused on Acute Myeloid Leukemia Research (151 papers), Hematopoietic Stem Cell Transplantation (68 papers) and Immune Cell Function and Interaction (40 papers). Øystein Bruserud collaborates with scholars based in Norway, United States and France. Øystein Bruserud's co-authors include Bjørn Tore Gjertsen, Håkon Reikvam, Kimberley Joanne Hatfield, Elisabeth Ersvær, Anita Ryningen, Randi Hovland, Annette K. Brenner, Astrid Olsnes Kittang, Brynjar Foss and Tor Henrik Anderson Tvedt and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Øystein Bruserud

345 papers receiving 8.1k citations

Hit Papers

Single Cell Profiling of ... 2004 2026 2011 2018 2004 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Øystein Bruserud 3.9k 3.9k 1.9k 1.7k 1.1k 350 8.2k
Martin Sattler 4.3k 1.1× 3.1k 0.8× 1.2k 0.6× 2.4k 1.4× 1.5k 1.4× 151 8.6k
Elvira Pelosi 4.5k 1.2× 1.9k 0.5× 1.4k 0.7× 1.5k 0.9× 1.1k 1.0× 170 7.9k
Adrian C. Newland 1.8k 0.5× 3.9k 1.0× 1.6k 0.9× 1.2k 0.7× 1.2k 1.1× 281 8.1k
Li Yu 4.8k 1.2× 1.8k 0.5× 1.6k 0.8× 2.0k 1.1× 498 0.4× 410 9.1k
Diane F. Jelinek 3.6k 0.9× 2.6k 0.7× 4.4k 2.3× 2.8k 1.6× 3.9k 3.5× 205 10.8k
Delong Liu 3.9k 1.0× 1.3k 0.3× 1.7k 0.9× 3.9k 2.2× 1.3k 1.2× 189 9.1k
Yoshiro Niitsu 3.8k 1.0× 1.8k 0.5× 943 0.5× 1.9k 1.1× 1.4k 1.3× 290 8.9k
Laura G. Corral 2.9k 0.7× 2.8k 0.7× 1.4k 0.7× 1.8k 1.0× 856 0.8× 61 6.0k
Daniel Kirchhofer 2.4k 0.6× 2.1k 0.5× 1.1k 0.6× 660 0.4× 828 0.7× 116 6.4k
Michael Fiegl 2.3k 0.6× 1.3k 0.3× 841 0.4× 1.9k 1.1× 559 0.5× 165 5.9k

Countries citing papers authored by Øystein Bruserud

Since Specialization
Citations

This map shows the geographic impact of Øystein Bruserud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øystein Bruserud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øystein Bruserud more than expected).

Fields of papers citing papers by Øystein Bruserud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øystein Bruserud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øystein Bruserud. The network helps show where Øystein Bruserud may publish in the future.

Co-authorship network of co-authors of Øystein Bruserud

This figure shows the co-authorship network connecting the top 25 collaborators of Øystein Bruserud. A scholar is included among the top collaborators of Øystein Bruserud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Øystein Bruserud. Øystein Bruserud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruserud, Øystein, et al.. (2024). Acute myeloid leukemia with rare recurring translocations—an overview of the entities included in the international consensus classification. Annals of Hematology. 103(4). 1103–1119. 2 indexed citations
2.
Hatfield, Kimberley Joanne, Øystein Bruserud, & Håkon Reikvam. (2022). Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients. Cancers. 14(12). 2910–2910. 4 indexed citations
3.
Mosevoll, Knut Anders, Håkon Reikvam, Øyvind Bruserud, et al.. (2022). Patients with Bacterial Sepsis Are Heterogeneous with Regard to Their Systemic Lipidomic Profiles. Metabolites. 13(1). 52–52. 7 indexed citations
4.
Hovland, Randi, et al.. (2020). Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment. SHILAP Revista de lepidopterología. 2020. 1–6. 2 indexed citations
5.
Aesöy, Reidun, Øystein Bruserud, Annette K. Brenner, et al.. (2019). A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 18(3). 567–578. 15 indexed citations
7.
Ersvær, Elisabeth, André Sulen, Håkon Reikvam, et al.. (2013). Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrine. BMC Pharmacology and Toxicology. 14(1). 35–35. 10 indexed citations
8.
Apelseth, Torunn Oveland, Tor Hervig, Tore Wentzel‐Larsen, et al.. (2011). A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia. European Cytokine Network. 22(1). 52–62. 17 indexed citations
11.
Øyan, Anne M., Trond Hellem Bø, Inge Jonassen, et al.. (2006). cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. International Journal of Oncology. 28(5). 1065–80. 6 indexed citations
12.
Bruserud, Øystein. (2005). TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL. Haematologica. 90(5). 579–579. 2 indexed citations
13.
14.
Gjertsen, Bjørn Tore, Anne M. Øyan, Bruz Marzolf, et al.. (2002). Analysis of Acute Myelogenous Leukemia: Preparation of Samples for Genomic and Proteomic Analyses. Journal of Hematotherapy & Stem Cell Research. 11(3). 469–481. 37 indexed citations
15.
Wendelbo, Øystein, Nils Glenjen, & Øystein Bruserud. (2002). Interleukin-7 (IL-7) in Patients Receiving Intensive Chemotherapy for Acute Myelogenous Leukemia: Studies of Systemic IL-7 Levels and IL-7 Responsiveness of Circulating T Lymphocytes. Journal of Interferon & Cytokine Research. 22(10). 1057–1065. 11 indexed citations
16.
Foss, Brynjar, et al.. (2001). Effects of Vascular Endothelial Growth Factor on Acute Myelogenous Leukemia Blasts. Journal of Hematotherapy & Stem Cell Research. 10(1). 81–93. 27 indexed citations
17.
Bruserud, Øystein, et al.. (2000). In Vitro Culture of Human Acute Myelogenous Leukemia (AML) Cells in Serum-Free Media: Studies of Native AML Blasts and AML Cell Lines. Journal of Hematotherapy & Stem Cell Research. 9(6). 923–932. 60 indexed citations
18.
Bruserud, Øystein, Brynjar Foss, Jenny Foss Abrahamsen, Bjørn Tore Gjertsen, & Peter Ernst. (2000). Autologous Stem Cell Transplantation As Post-Remission Therapy in Adult Acute Myelogenous Leukemia: Does Platelet Contamination of Peripheral Blood Mobilized Stem Cell Grafts Influence the Risk of Leukemia Relapse?. Journal of Hematotherapy & Stem Cell Research. 9(4). 433–443. 16 indexed citations
19.
Bruserud, Øystein & Elling Ulvestad. (2000). Cytokine Responsiveness of Mitogen-Activated T Cells Derived from Acute Leukemia Patients with Chemotherapy-Induced Leukopenia. Journal of Interferon & Cytokine Research. 20(11). 947–954. 14 indexed citations
20.
Bruserud, Øystein, et al.. (1995). Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.. PubMed. 9(11). 1910–20. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026